{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T07:40:22Z","timestamp":1769845222666,"version":"3.49.0"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,4,4]],"date-time":"2014-04-04T00:00:00Z","timestamp":1396569600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1471-2334-14-183","type":"journal-article","created":{"date-parts":[[2014,4,7]],"date-time":"2014-04-07T19:49:37Z","timestamp":1396900177000},"source":"Crossref","is-referenced-by-count":32,"title":["Effect of vancomycin serum trough levels on outcomes in patients with nosocomial pneumonia due to Staphylococcus aureus: a retrospective, post hoc, subgroup analysis of the Phase 3 ATTAIN studies"],"prefix":"10.1186","volume":"14","author":[{"given":"Steven L","family":"Barriere","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin E","family":"Stryjewski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G Ralph","family":"Corey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fredric C","family":"Genter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ethan","family":"Rubinstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,4,4]]},"reference":[{"issue":"3","key":"3094_CR1","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1378\/chest.128.3.1414","volume":"128","author":"CA DeRyke","year":"2005","unstructured":"DeRyke CA, Lodise TP, Rybak MJ, McKinnon PS: Epidemiology, treatment, and outcomes of nosocomial bacteremic Staphylococcus aureus pneumonia. Chest. 2005, 128 (3): 1414-1422. 10.1378\/chest.128.3.1414.","journal-title":"Chest"},{"issue":"4","key":"3094_CR2","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1164\/rccm.200405-644ST","volume":"171","author":"American Thoracic Society; Infectious Diseases Society of America","year":"2005","unstructured":"American Thoracic Society; Infectious Diseases Society of America: Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med. 2005, 171 (4): 388-416.","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"3094_CR3","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1086\/600877","volume":"49","author":"MJ Rybak","year":"2009","unstructured":"Rybak MJ, Lomaestro BM, Rotschafer JC, Moellering RC, Craig WA, Billeter M, Dalovisio JR, Levine DP: Vancomycin therapeutic guidelines: a summary of consensus recommendations from the Infectious Diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists. Clin Infect Dis. 2009, 49 (3): 325-327. 10.1086\/600877.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"3094_CR4","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1378\/chest.130.4.947","volume":"130","author":"MN Jeffres","year":"2006","unstructured":"Jeffres MN, Isakow W, Doherty JA, McKinnon PS, Ritchie DJ, Micek ST, Kollef MH: Predictors of mortality for methicillin-resistant Staphylococcus aureus health-care-associated pneumonia: specific evaluation of vancomycin pharmacokinetic indices. Chest. 2006, 130 (4): 947-955. 10.1378\/chest.130.4.947.","journal-title":"Chest"},{"issue":"1","key":"3094_CR5","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1517\/14740330903413514","volume":"9","author":"ED Hermsen","year":"2010","unstructured":"Hermsen ED, Hanson M, Sankaranarayanan J, Stoner JA, Florescu MC, Rupp ME: Clinical outcomes and nephrotoxicity associated with vancomycin trough concentrations during treatment of deep-seated infections. Expert Opin Drug Saf. 2010, 9 (1): 9-14. 10.1517\/14740330903413514.","journal-title":"Expert Opin Drug Saf"},{"key":"3094_CR6","volume-title":"Linezolid vs vancomycin in the treatment of nosocomial pneumonia proven due to methicillin-resistant Staphylococcus aureus (abstract LB-49)","author":"M Kunkel","year":"2010","unstructured":"Kunkel M, Chastre JE, Kollef MH, Niederman MS, Shorr AF, Wunderink RG, McGee W, Olvey S, Reisman A, Baruch A: Infectious Diseases Society of America (IDSA) 48th Annual Meeting. Linezolid vs vancomycin in the treatment of nosocomial pneumonia proven due to methicillin-resistant Staphylococcus aureus (abstract LB-49). 2010, Canada: Vancouver, BC"},{"issue":"6","key":"3094_CR7","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1016\/j.clinthera.2007.06.014","volume":"29","author":"MN Jeffres","year":"2007","unstructured":"Jeffres MN, Isakow W, Doherty JA, Micek ST, Kollef MH: A retrospective analysis of possible renal toxicity associated with vancomycin in patients with health care-associated methicillin-resistant Staphylococcus aureus pneumonia. Clin Ther. 2007, 29 (6): 1107-1115. 10.1016\/j.clinthera.2007.06.014.","journal-title":"Clin Ther"},{"issue":"4","key":"3094_CR8","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1086\/600884","volume":"49","author":"TP Lodise","year":"2009","unstructured":"Lodise TP, Patel N, Lomaestro BM, Rodvold KA, Drusano GL: Relationship between initial vancomycin concentration-time profile and nephrotoxicity among hospitalized patients. Clin Infect Dis. 2009, 49 (4): 507-514. 10.1086\/600884.","journal-title":"Clin Infect Dis"},{"issue":"8","key":"3094_CR9","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1093\/cid\/cir078","volume":"52","author":"N Patel","year":"2011","unstructured":"Patel N, Pai MP, Rodvold KA, Lomaestro B, Drusano GL, Lodise TP: Vancomycin: we can't get there from here. Clin Infect Dis. 2011, 52 (8): 969-974. 10.1093\/cid\/cir078.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"3094_CR10","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1093\/cid\/ciq031","volume":"52","author":"E Rubinstein","year":"2011","unstructured":"Rubinstein E, Lalani T, Corey GR, Kanafani ZA, Nannini EC, Rocha MG, Rahav G, Niederman MS, Kollef MH, Shorr AF, Lee PC, Lentnek AL, Luna CM, Fagon JY, Torres A, Kitt MM, Genter FC, Barriere SL, Friedland HD, Stryjewski ME, for the ATTAIN Study Group: Telavancin versus vancomycin for hospital-acquired pneumonia due to gram-positive pathogens. Clin Infect Dis. 2011, 52 (1): 31-40. 10.1093\/cid\/ciq031.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"3094_CR11","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.ijantimicag.2010.10.013","volume":"37","author":"A Wong-Beringer","year":"2011","unstructured":"Wong-Beringer A, Joo J, Tse E, Beringer P: Vancomycin-associated nephrotoxicity: a critical appraisal of risk with high-dose therapy. Int J Antimicrob Agents. 2011, 37 (2): 95-101. 10.1016\/j.ijantimicag.2010.10.013.","journal-title":"Int J Antimicrob Agents"},{"issue":"12","key":"3094_CR12","doi-asserted-by":"publisher","first-page":"5475","DOI":"10.1128\/AAC.00168-11","volume":"55","author":"JA Bosso","year":"2011","unstructured":"Bosso JA, Nappi J, Rudisill C, Wellein M, Bookstaver PB, Swindler J, Mauldin PD: Relationship between vancomycin trough concentrations and nephrotoxicity: a prospective multicenter trial. Antimicrob Agents Chemother. 2011, 55 (12): 5475-5479. 10.1128\/AAC.00168-11.","journal-title":"Antimicrob Agents Chemother"},{"issue":"19","key":"3094_CR13","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1001\/archinte.166.19.2138","volume":"166","author":"LK Hidayat","year":"2006","unstructured":"Hidayat LK, Hsu DI, Quist R, Shriner KA, Wong-Beringer A: High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity. Arch Intern Med. 2006, 166 (19): 2138-2144. 10.1001\/archinte.166.19.2138.","journal-title":"Arch Intern Med"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2334-14-183\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-14-183.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-14-183","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-14-183.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T10:03:45Z","timestamp":1548237825000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/1471-2334-14-183"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,4]]},"references-count":13,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["3094"],"URL":"https:\/\/doi.org\/10.1186\/1471-2334-14-183","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,4]]},"article-number":"183"}}